BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33177192)

  • 21. Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
    Pushko P; Tretyakova I; Hidajat R; Sun X; Belser JA; Tumpey TM
    Vaccine; 2018 Jul; 36(29):4346-4353. PubMed ID: 29885769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
    Tretyakova I; Hidajat R; Hamilton G; Horn N; Nickols B; Prather RO; Tumpey TM; Pushko P
    Virology; 2016 Jan; 487():163-71. PubMed ID: 26529299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.
    Qiu X; Duvvuri VR; Gubbay JB; Webby RJ; Kayali G; Bahl J
    Influenza Other Respir Viruses; 2017 Sep; 11(5):445-456. PubMed ID: 28715148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
    de Jonge J; Isakova-Sivak I; van Dijken H; Spijkers S; Mouthaan J; de Jong R; Smolonogina T; Roholl P; Rudenko L
    Mol Ther; 2016 May; 24(5):991-1002. PubMed ID: 26796670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of H7N9 highly pathogenic avian influenza virus in the context of vaccination.
    Hou Y; Deng G; Cui P; Zeng X; Li B; Wang D; He X; Yan C; Zhang Y; Li J; Ma J; Li Y; Wang X; Tian G; Kong H; Tang L; Suzuki Y; Shi J; Chen H
    Emerg Microbes Infect; 2024 Dec; 13(1):2343912. PubMed ID: 38629574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.
    Chang P; Sealy JE; Sadeyen JR; Iqbal M
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30282714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
    Bahl K; Senn JJ; Yuzhakov O; Bulychev A; Brito LA; Hassett KJ; Laska ME; Smith M; Almarsson Ö; Thompson J; Ribeiro AM; Watson M; Zaks T; Ciaramella G
    Mol Ther; 2017 Jun; 25(6):1316-1327. PubMed ID: 28457665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies.
    Ho HT; Qian HL; He F; Meng T; Szyporta M; Prabhu N; Prabakaran M; Chan KP; Kwang J
    Clin Vaccine Immunol; 2009 May; 16(5):726-32. PubMed ID: 19321691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets.
    Park J; Fong Legaspi SL; Schwartzman LM; Gygli SM; Sheng ZM; Freeman AD; Matthews LM; Xiao Y; Ramuta MD; Batchenkova NA; Qi L; Rosas LA; Williams SL; Scherler K; Gouzoulis M; Bellayr I; Morens DM; Walters KA; Memoli MJ; Kash JC; Taubenberger JK
    Sci Transl Med; 2022 Jul; 14(653):eabo2167. PubMed ID: 35857640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza viruses with rearranged genomes as live-attenuated vaccines.
    Pena L; Sutton T; Chockalingam A; Kumar S; Angel M; Shao H; Chen H; Li W; Perez DR
    J Virol; 2013 May; 87(9):5118-27. PubMed ID: 23449800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassortment and adaptive mutations of an emerging avian influenza virus H7N4 subtype in China.
    Qu B; Li X; Cardona CJ; Xing Z
    PLoS One; 2020; 15(1):e0227597. PubMed ID: 31951605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells.
    Yan LM; Lau SPN; Poh CM; Chan VSF; Chan MCW; Peiris M; Poon LLM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses.
    Ghafoor D; Zeb A; Ali SS; Ali M; Akbar F; Ud Din Z; Ur Rehman S; Suleman M; Khan W
    J Biomol Struct Dyn; 2024 Apr; 42(7):3641-3658. PubMed ID: 37222664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice.
    Murray J; Martin DE; Hosking S; Orr-Burks N; Hogan RJ; Tripp RA
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.
    Wang L; Chang TZ; He Y; Kim JR; Wang S; Mohan T; Berman Z; Tompkins SM; Tripp RA; Compans RW; Champion JA; Wang BZ
    Nanomedicine; 2017 Jan; 13(1):253-262. PubMed ID: 27622321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.
    Yang H; Carney PJ; Chang JC; Guo Z; Stevens J
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription/Replication Efficiency of the Modified Segment.
    Furusawa Y; Yamada S; da Silva Lopes TJ; Dutta J; Khan Z; Kriti D; van Bakel H; Kawaoka Y
    mBio; 2019 Oct; 10(5):. PubMed ID: 31575766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development.
    Ducatez MF; Bahl J; Griffin Y; Stigger-Rosser E; Franks J; Barman S; Vijaykrishna D; Webb A; Guan Y; Webster RG; Smith GJ; Webby RJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):349-54. PubMed ID: 21173241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.
    Watanabe T; Watanabe S; Kim JH; Hatta M; Kawaoka Y
    J Virol; 2008 Mar; 82(5):2486-92. PubMed ID: 18160446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.
    Terajima M; Co MD; Cruz J; Ennis FA
    J Infect Dis; 2015 Oct; 212(7):1052-60. PubMed ID: 25795791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.